Momentum-wise, MU keeps outpacing NOW on volume and sentiment, while NOW’s price action looks capped. If the narrative stays that MU is the agile disruptor, that trend likely continues until a big catalyst shifts the balance.
I’m torn—NOW’s stability feels safer, but MU’s innovation excites me. I’d rather own both and see where the ecosystem goes.
Feels like NOW and MU are clashing over strategy.
I'm on the sidelines for now. The $30 talk excites me, but I don't want to get caught in a fade. I'd rather wait for a pullback and see if China demand or margins actually improve.
Everyone's cheering the move, but NIO's momentum feels fragile; I'd expect a pause before any real breakout.
Market hype again, feels like chasing NIO spikes.
Hard to buy a 29.3 pop without higher rates and thin liquidity. If funding tightens, CELH could fade fast.
Biotech names staying choppy; CELH drifts with peers.
Quick bounce or fakeout before next leg?
